FMI suggests the Cytokinins market was valued at USD 1.9 billion in 2025, increased to USD 2.1 billion in 2026, and is projected to reach USD 4.3 billion by 2036, reflecting a 7.4% CAGR during 2026 to 2036. By segment, 6-Benzylaminopurine (6-BAP) lead the Type category with a 45.8% share in 2026, while Agriculture dominates the End Use segment with a 47.3% share in 2026.